Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Skrit37on Dec 17, 2020 6:56pm
293 Views
Post# 32136750

RE:mRNA- science in the Moderna vaccine and Stage's Sentinel

RE:mRNA- science in the Moderna vaccine and Stage's Sentinel
LithLover wrote: Changes in mRNA expression can be measured in blood and serve as specific early cancer indicators for cancer and other diseases. StageZero Life Sciences discovered this principle, named it the Sentinel Principle®, and patented the technology platform behind it. 
------------------
Here is an excellent article on mRNA and the CoVid Moderna vaccine.  Good to understand how mRNA works as it's what the Sentinel Principle was based on 

It talks to mRNA being the future for vaccines.  The same idea of blood being a messenger that Stagezero uses for liquid biopsy and cancer screening.


https://www.health.harvard.edu/blog/why-are-mrna-vaccines-so-exciting-2020121021599





Ive been thinking the same thing...we have the best tech patented for early cancer detection/ plus all of the other detection avenues it can evolve into...                             
 
Small, Subtle Changes in Your Messenger RNA (mRNA) Can Identify Cancer Early - And We've Developed the Science that Finds Them
Most people think of cancer as changes, or mutations, in the sequence of DNA that lead to uncontrolled cell division. However, in between DNA and proteins (your cell's building blocks) is another layer of information called messenger RNA (mRNA) and it’s a crucial link to finding cancer. Changes in mRNA expression can be measured in blood and serve as specific early cancer indicators for cancer and other diseases. StageZero Life Sciences discovered this principle, named it the Sentinel Principle®, and patented the technology platform behind it. The Sentinel Principle has already been used to develop the first liquid biopsy for Colorectal Cancer (ColonSentry®) and is the foundation of Aristotle® - our next generation test for multiple cancers.

Once the competition has exhausted/tried all other types of methods for early cancer detection..they will  discover they cant beat our specificity and sensitivity..


You would think these companies have looked at mrna gene expression and noticed they cant, because we have the key parts patented already, thanks to the Sentinel Principle







<< Previous
Bullboard Posts
Next >>